A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumors
暂无分享,去创建一个
E. Raymond | F. Goldwasser | S. Faivre | A. Gianella-Borradori | A. Awada | L. Trandafir | T. besse-Hammer | J. Alexandre | N. Rejeb | V. Jego